MedPath

Certara

🇺🇸United States
Ownership
-
Employees
1.3K
Market Cap
-
Website
Introduction

Cerrado Gold Inc is a precious metals mining and exploration company building a portfolio of assets in South America. The company owns the Minera Don Nicolas Project, located in Santa Cruz, Argentina. It is also focused on exploration at its Monte do Carmo gold Project in Tocantins State, Brazil.

Clinical Trials

3

Active:0
Completed:1

Trial Phases

2 Phases

Phase 1:1
Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Not Applicable
1 (50.0%)
Phase 1
1 (50.0%)

International Registry of Healthcare Workers Exposed to COVID-19 Patients (UNITY Global)

Completed
Conditions
Covid19
SARS-CoV Infection
First Posted Date
2020-11-12
Last Posted Date
2023-04-04
Lead Sponsor
Certara
Target Recruit Count
6808
Registration Number
NCT04626076
Locations
🇵🇰

Aga Khan University, Karachi, Pakistan

News

Certara Expands Clinical Technology Partnership with Merck to Streamline Data Management

Certara and Merck have expanded their clinical technology collaboration to include metadata repository and data standards workflow management through the Pinnacle 21 platform.

IRA Biosimilar Incentives Drive Measurable Uptake in US Healthcare Facilities

The Inflation Reduction Act's 2% Medicare reimbursement boost for qualifying biosimilars has led to measurable increases in adoption, with 45% of surveyed facilities reporting slight increases and 14% reporting significant increases in utilization.

Certara Launches Non-Animal Navigator Solution to Reduce Animal Testing in Drug Development

Certara has introduced the Non-Animal Navigator solution to help pharmaceutical companies reduce reliance on animal testing in preclinical safety studies, aligning with FDA's recent roadmap initiative.

AI Simulations Enhance Clinical Trial Efficiency and Accuracy in Drug Development

AI-driven simulations are improving clinical trial success rates by preemptively modeling trials and optimizing dosing strategies.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.